A 42-year-old woman from Virginia, USA, presents with a 5-day history of high fever (40°C), severe headache, and myalgia. On examination, she has a petechial rash that began on her wrists and ankles and has now spread to her trunk and legs, including the palms and soles. She recalls a tick bite on her calf 2 weeks ago. Platelet count is 95,000/μL, and serum creatinine is 1.8 mg/dL. What is the most likely diagnosis?

Explanation

## Clinical Diagnosis: Rocky Mountain Spotted Fever (RMSF) ### Key Clinical Features **Key Point:** RMSF is characterized by a **centripetal rash** (starting on wrists/ankles and spreading toward the trunk) that **involves the palms and soles** — a critical distinguishing feature. The rash appears 3–5 days after fever onset. **High-Yield:** RMSF is the most severe rickettsial disease in North America, with mortality rates of 5–10% if untreated and up to 20% in delayed treatment. Early recognition and treatment with doxycycline is life-saving. ### Diagnostic Criteria Met | Feature | RMSF | Scrub Typhus | Leptospirosis | Meningococcemia | |---------|------|--------------|---------------|------------------| | **Rash onset site** | Wrists/ankles (centripetal) | Trunk → extremities (centrifugal) | Rare | Generalized petechiae | | **Palms/soles involved** | Yes (characteristic) | No | No | May be involved | | **Eschar** | No | Yes (80–90%) | No | No | | **Vector** | Dermacentor tick | Trombiculid mite | Rodent urine exposure | Human-to-human | | **Thrombocytopenia** | Common (60–70%) | Mild/absent | Mild | Severe (DIC) | | **Renal involvement** | Yes (AKI) | Rare | Common (leptospirosis) | Possible | | **Endemic region** | North America (esp. SE USA) | Asia-Pacific | Worldwide | Worldwide | **Clinical Pearl:** The **combination of centripetal rash + palms/soles involvement + tick exposure + thrombocytopenia + AKI** is the classic tetrad for RMSF. The geographic history (Virginia) and tick bite history are crucial epidemiologic clues. ### Pathophysiology 1. **Vector:** *Dermacentor* tick (dog tick, wood tick) transmits *Rickettsia rickettsii* 2. **Inoculation:** Tick saliva introduces rickettsiae into dermis; **no eschar forms** (unlike scrub typhus) 3. **Vascular injury:** Rickettsiae infect endothelial cells → vasculitis, increased vascular permeability, thrombocytopenia 4. **Multi-organ involvement:** Rash (vasculitis), renal dysfunction (acute tubular necrosis), CNS (meningitis), pulmonary (ARDS) ### Rash Progression: Centripetal vs. Centrifugal ```mermaid flowchart TD A[Rickettsial Rash Patterns]:::outcome A --> B{Rash onset location?}:::decision B -->|Wrists/ankles first| C[Spreads toward trunk]:::action C --> D[Centripetal pattern]:::outcome D --> E[RMSF]:::outcome B -->|Trunk first| F[Spreads to extremities]:::action F --> G[Centrifugal pattern]:::outcome G --> H[Scrub typhus]:::outcome ``` **Mnemonic:** **RMSF = Rash on Medial wrists/ankles, Spreads Facially (toward trunk)** ### Complications in This Case **Warning:** Thrombocytopenia (95,000/μL) and elevated creatinine (1.8 mg/dL) indicate multi-organ involvement. Without immediate doxycycline therapy, progression to: - Disseminated intravascular coagulation (DIC) - Acute respiratory distress syndrome (ARDS) - Acute kidney injury requiring dialysis - Death ### Treatment - **First-line:** Doxycycline 100 mg IV/PO BD (do NOT wait for serology confirmation) - **Duration:** 7–10 days - **Pediatric/pregnancy:** Chloramphenicol 50 mg/kg/day in 4 divided doses - **Prognosis:** Mortality <1% if treated within 5 days of rash onset; >20% if delayed >8 days **Clinical Pearl:** In endemic areas, **empiric doxycycline should be started on clinical suspicion alone** — waiting for serology confirmation increases mortality risk.